Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for AtriCure (ATRC) over the last 7 years, with Q3 2025 value amounting to -$0.01.

  • AtriCure's EPS (Weighted Average and Diluted) rose 9411.76% to -$0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.61, marking a year-over-year increase of 2650.6%. This contributed to the annual value of -$0.95 for FY2024, which is 4420.15% down from last year.
  • As of Q3 2025, AtriCure's EPS (Weighted Average and Diluted) stood at -$0.01, which was up 9411.76% from -$0.13 recorded in Q2 2025.
  • In the past 5 years, AtriCure's EPS (Weighted Average and Diluted) ranged from a high of $2.11 in Q3 2021 and a low of -$0.38 during Q1 2021
  • Over the past 5 years, AtriCure's median EPS (Weighted Average and Diluted) value was -$0.2 (recorded in 2023), while the average stood at -$0.1.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 201818.18% in 2021, then plummeted by 13333.33% in 2023.
  • AtriCure's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.3 in 2021, then soared by 70.0% to -$0.09 in 2022, then plummeted by 133.33% to -$0.21 in 2023, then tumbled by 57.85% to -$0.33 in 2024, then soared by 96.98% to -$0.01 in 2025.
  • Its last three reported values are -$0.01 in Q3 2025, -$0.13 for Q2 2025, and -$0.14 during Q1 2025.